DOG1 immunoreactivity in uterine leiomyosarcomas

Journal of Clinical Pathology

Volumn 66, Issue 1, 2013, Pages 40-43

  Sah, Shatrughan P ^a   McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DOG1; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; IMMUNOREACTIVITY; LEIOMYOMA; PRIORITY JOURNAL; STAINING; TUMOR CELL; UTERUS SARCOMA;

CHLORIDE CHANNELS; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 84871928656     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201150     Document Type: Article

References (24)

1. Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ Blausteins's pathology of the female genital tract. New York: Springer-Verlag, 1994:849-914.
2. Wingen CB, Pauwels PA, Debiec-Rychter M, et al. Uterine gastrointestinal stromal tumour (GIST). Gynecol Oncol 2005;97:970-2. (Pubitemid 40824679)
3. Terada T. Gastrointestinal stromal tumor of the uterus: a case report with genetic analysis of c-kit and PDGFRA genes. Int J Gynecol Pathol 2009;28:29-34.
4. Peitsidis P, Zarganis P, Trichia H, et al. Extragastrointestinal stromal tumor mimicking a uterine tumor. A rare clinical entity. Int J Gynecol Cancer 2008;18:1115-18.
5. Winter WE III, Seidman JD, Krivak TC, et al. Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus. Gynecol Oncol 2003;91:3-8. (Pubitemid 37188588)
6. Wang L, Felix JC, Lee JL, et al. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol Oncol 2003;90:402-6. (Pubitemid 36952035)
7. Erdogan G, Bassorgun CI, Pestereli HE, et al. C-kit protein expression in uterine and ovarian mesenchymal tumours. APMIS 2007;115:204-9. (Pubitemid 46426648)
8. Klein WM, Kurman RJ. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary. Int J Gynecol Pathol 2003;22:181-4. (Pubitemid 36348793)
9. Raspollini MR, Amunni G, Villanucci A, et al. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment. Clin Cancer Res 2004;10:3500-3. (Pubitemid 38685458)
10. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004;165:107-13. (Pubitemid 38821818)
11. Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009;296:G1370-81.
12. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008;32:210-18. (Pubitemid 351172135)
13. Liegl B, Hornick JL, Corless CL, et al. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol 2009;33:437-46.
14. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol 2009;33:1401-8.
15. Wong NA, Shelley-Fraser G. Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour. Histopathology 2010;57:250-8.
16. Novelli M, Rossi S, Rodriguez-Justo M, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology 2010;57:259-70.
17. Wong NA. Gastrointestinal stromal tumours-an update for histopathologists. Histopathology 2011;59:807-21.
18. Lopes LF, West RB, Bacchi LM, et al. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol 2010;18:333-7.
19. Hwang DG, Qian X, Hornick JL. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Am J Clin Pathol 2011;135:448-53.
20. Lam MM, Corless CL, Goldblum JR, et al. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol 2006;25:288-92. (Pubitemid 44610045)
21. Nagase S, Mikami Y, Moriya T, et al. Vaginal tumors with histologic and immunocytochemical feature of gastrointestinal stromal tumor: two cases and review of the literature. Int J Gynecol Cancer 2007;17:928-33. (Pubitemid 47063338)
22. Foster R, Solano S, Mahoney J, et al. Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT. Gynecol Oncol 2006;101:363-6.
23. Irving JA, Lerwill MF, Young RH. Gastrointestinal stromal tumors metastatic to the ovary: a report of five cases. Am J Surg Pathol 2005;29:920-6. (Pubitemid 40885015)
24. Wong NA, Melegh Z. Gastrointestinal stromal tumours can express CD10 and epithelial membrane antigen but not oestrogen receptor or HMB45. Histopathology 2011;59:781-5.